How Covered is IVF in the United States?

IVF insurance coverage varies greatly among larger employers

8:00 AM

View Transcript

Analysis of in vitro fertilization policy plans offers a better picture of what kind of access patients actually have. Read the full article here.

Transcript

Host: 

Welcome to Health Lab, your destination for news and stories about the future of healthcare. 

Today: IVF insurance coverage varies greatly among larger employers. An analysis of in vitro fertilization policy plans offers a better picture of what kind of access patients actually have.

With President Trump’s executive order to expand access to families for in vitro fertilization, or IVF, the federal government has been giving special attention to insurance coverage of this important infertility treatment.

Luckily, James Dupree, M.D., M.P.H., and Anna Kirkland, J.D., Ph.D., have been working on, and researching, this topic for years.

“The World Health Organization and the American Society of Reproductive Medicine state that infertility is a disease,” Dupree explained.

“Much like patients should have access to medicines that treat diabetes and blood pressure, I believe strongly patients should have access to IVF,” explained Dupree, a urologist who sees firsthand how patients struggle to pay for these types of fertility treatments; a single round of IVF treatment can range anywhere from $15,000 to $20,000, without a guarantee of a successful pregnancy.

Dupree and Kirkland’s recent data, published in the Journal of Assisted Reproductive Genetics, revealed more on the current state of employer insurance plans for IVF.

“One of our previous papers found that patients were willing to pay $5,000 per cycle of IVF, so we started looking at IVF coverage policies at self-insured employers that are able to design their own insurance coverage policies,” said Kirkland.

State mandates have begun to pass around the country to try to bring IVF costs for patients down instead of having it be an entirely out-of-pocket cost for those who can afford it.

But it’s not that simple, as their findings showed.

“Those state IVF coverage mandates don’t apply to every employer, however, and the employers that are exempt, called self-insured employers, in our study, didn’t offer any more IVF coverage than the national average,” said Kirkland.

“The policy and legal landscape for IVF coverage is highly fragmented,” she explained.

More about the paper:

Only 15 states and Washington, DC, have passed a law that mandate private insurance coverage of IVF, but each mandate is significantly  different.

For instance, Hawaii states that a couple must be infertile for five years before receiving IVF insurance coverage, while Utah offers up to $4,000 towards IVF-related medicines and procedures.

“So, there’s coverage, but not great coverage and not the same across the board,” said Dupree.

Their team decided to break this down further, in states with mandates for IVF coverage, by looking at self-insured companies that don't have to follow the mandates.

Self-insured companies tend to be larger employers, like the University of Michigan, for example, who bear the risk of paying claims for their employees and their dependents out of their own funds.

These companies have to follow federal laws, but not state laws, regarding insurance coverage, and current federal law doesn't include an IVF coverage mandate.

The other kind of employer people can use is a fully insured one, which means an insurance company bears the risk of an employer’s plan for its employees, and is paid a set amount by that employer.

These employer plans need to abide by state mandates.

And that’s important, says Kirkland, because only 34% of people get insurance from these fully-insured companies, whereas 66% of people get insurance from self-insured employers.

“So what we did in the research is looked at self-insured employers who were headquartered in one of those states with the IVF coverage mandates. We wondered if being in a mandate state would pressure them to match coverage. What we found was that those self-insured employers are not offering any more IVF coverage than the national average in those states,” she added.

“Their coverage is low when you compare it to the fully-insured companies in those states that must follow the mandates and offer coverage about 100% of the time. The self-insured employers only provided IVF coverage about 40% of the time.”

An additional finding in their study was that, among self-insured companies that offered coverage, the details of the coverage varied widely.

“We found examples of companies covering IVF, but they only cover $5,000 to $10,000, which usually won’t even cover one IVF attempt. And then we found others that cover 5 to 6 cycles of IVF.”

Coverage by self-insured companies varied by business sector.

Educational service companies, manufacturers, finance and insurance companies were very likely to offer IVF benefits, but industries like health care services, hotel and hospitality companies were less so.

In general, non-union employer plans offered IVF coverage more commonly than union plans did.

So, what’s next?

Dupree and Kirkland’s team plans to focus on expanding their review across the country.

They hope to put together prototypes of ideal benefit coverage plans that could be used in a meaningful way as the government examines what IVF coverage is available and what could be available in the future.

For now, Dupree emphasizes the need for employees to understand their insurance plan’s IVF benefits before they may actually need to use it.

“You need to really read the details about the IVF coverage, not just hear that it’s ‘covered’. You may not care about it in that moment, but then when it does matter to you, it really matters.”

A reminder that all Health Lab content including health news, best practices and research insights are for informational purposes only, and are not a substitute for professional medical guidance. Always seek the advice of a health care provider for questions about your health and treatment options.

For more on this story and for others like it, visit michiganmedicine.org/health-lab where you can also subscribe to our Health Lab newsletters to receive the latest in health, wellness and medical research information to your inbox each week. Health Lab is a part of the Michigan Medicine Podcast Network, and is produced by the Michigan Medicine Department of Communication. You can subscribe to Health Lab wherever you listen to podcasts.


More Articles About:

Healthcare Health Insurance Genetics fertility Infertility
Health Lab Podcast in brackets with a background with a dark blue translucent layers over cells

Health Lab Podcast

Listen to more Health Lab podcasts - a part of the Michigan Medicine Podcast Network.

Featured News & Stories

UMich Med Mosaic on blue background with colorful geometric shapes
UMich Med Mosaic

Beyond the White Coat: Disability, Neurodiversity and Advocacy in Medical School

In this episode of UMich Med Mosaic, host Mackenzie Kay sits down with medical students Jill Maudlin, Sarah Renberg and Bella Johnson to discuss their experiences as disabled and neurodivergent trainees at the University of Michigan Medical School. They reflect on the personal journeys that led them to medicine, the challenges and strengths that accompany living with disabilities and chronic health conditions and the importance of representation within the medical profession. The conversation explores how disability shapes their approaches to patient care, advocacy and teamwork, as well as the role of the Medical Students for Disability Health Advocacy (MSDHA) organization in creating community and advancing accessibility initiatives. They also discuss Michigan’s accommodations in medical education, efforts to improve disability-related curriculum content and the importance of building a culture where disabled and neurodivergent students can thrive.
Minding Memory with a microphone and a shadow of a microphone on a blue background
Minding Memory

Antipsychotic Use in Nursing Homes: Balancing Medication Safety, Policy, and Dementia Care

In this episode, Lauren Gerlach and Matt Davis speak with Theresa Shireman, PhD, Director of the Center for Gerontology and Healthcare Research and a Professor of Health Services, Policy and Practice and Epidemiology at the Brown University School of Public Health. Dr. Shireman’s research focuses on pharmaceutical policy, pharmacoepidemiology, health services research, and medication use among vulnerable populations. Dr. Shireman discusses her recent study, "Impact of Federal Antipsychotic Use Policy in Nursing Homes on New Diagnoses for Approved Indications in Dementia Residents," published in the Journal of the American Geriatrics Society. The study examines whether federal policies designed to reduce antipsychotic use in nursing homes were associated with increases in new diagnoses of conditions, such as schizophrenia, that exclude residents from publicly report antipsychotic quality measures. Using an interrupted time-series design, the researchers examined changes following the 2012 National Partnership to Improve Dementia Care and the 2015 addition of antipsychotic use to the Nursing home Five-Star Quality Rating System. They found that neither policy was associated with an increase in new exclusionary diagnossees, challenging concerns that nursing homes were increasingly assigning these diagnoses to circumvent restrictions on antipsychotic use. The conversation also explores the benefits and risks of antipsychotic medications for people living with dementia, including the potential for serious adverse effects such as sedation, falls, stroke, and increased mortality. Dr. Shireman discusses how public reporting and financial incentives can influence prescribing practices,the limitations of using a single quality measure to evaluate nursing home care, and the importance of balancing medication safety and residents’ individual needs. The discussion highlights the need for shared decision-making among clinicians, nursing home staff, residents, and families, as well as greater investment in staffing, resources, and nonpharmacological approaches to improve quality of life for people living with dementia. The transcript for this episode can be found here.
Health Lab Podcast in brackets with a background with a dark blue translucent layers over cells
Health Lab Podcast

Human Rabies Exposures Growing Across the Country

Infectious disease experts weigh in on what to do if you think you’ve been exposed to rabies.
Well-Being at Michigan Medicine with Dr. Elizabeth Harry
Well-Being at Michigan Medicine

Learning Together: Making Space for Growth at Work

What if well-being starts with how we learn together? On this episode of Well-Being at Michigan Medicine, Elizabeth Harry, M.D., is joined by Rajesh Mangrulkar, M.D., FNAP, Executive Director of U-M’s Center for Interprofessional Practice and Education (IPE), Executive Director of Michigan Medicine RISE (Research. Innovation. Scholarship. Education), and primary care physician of internal medicine whose work focuses on organizational leadership and innovation, and Johnny McGraw, M.A., Marketing & Communications Specialist for both RISE and IPE, about building teams through human connection, psychological safety and learning. They discuss a meeting practice, why leaders shape culture and how investments in collaboration can help health care teams work without asking people to carry everything alone.
A hand holding a prescription bottle with a dollar bill in it
Health Lab

Top 7 tips for choosing Medicare prescription drug coverage for 2027

Prescription drug coverage through Medicare Advantage and Part D plans in traditional Medicare has changed for 2027, and older adults may not know about programs that could help with costs.
Gene editing, conceptual illustration. DNA (deoxyribonucleic acid) double helix under a magnifying glass
Health Lab

Gene editing is coming for common diseases. Are we ready?

Gene therapies may offer one-time treatment for disease, but experts say safety, reversibility, cost and long-term monitoring must guide use.